China 3D Imaging Market Analysis

China 3D Imaging Market Analysis


$ 3999

China's 3D imaging market is projected to grow from $ 2.44 Bn in 2022 to $ 9.18 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by rising healthcare spending and rising chronic illness rates, driving up demand for better medical imaging technologies. The market is segmented by product, application, end-user, and portability. Some of the major players include Canon Medical Systems Corporation, GE Healthcare, Mindray Medical International Limited & Fussen Technology.

ID: IN10CNDH001 CATEGORY: Digital Health GEOGRAPHY: China AUTHOR: Vidhi Upadhyay

Buy Now

China 3D Imaging Market Executive Summary

China's 3D imaging market is projected to grow from $ 2.44 Bn in 2022 to $ 9.18 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. China's healthcare industry has been growing rapidly in recent years, driven by factors such as an aging population and increased government spending. Health expenditure (% of GDP) of China was predicted to decrease dramatically from 8.1 percent in 2021 to 2.8% in 2022 due to the widespread outbreak of Omicron and then raise back to 4.3% in 2023 according to the World Health Organization (WHO) Global Health Expenditure database. The four biggest causes of morbidity and death in China, according to the Global Burden of Disease Study (GBD), are ischemic heart disease, stroke, chronic obstructive pulmonary disease, and lung cancer making it a large market space for the 3D Imaging market to aid better diagnostics and treatments for patients.

3D imaging creates a three-dimensional depiction of a patient's interior anatomy, which provides precise anatomical information and can help with the diagnosis and monitoring of a variety of medical conditions. Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, X-ray Imaging Systems, 3D ultrasound, and Nuclear Imaging system is useful in a range of medical disciplines such as cardiology, neurology, cancer, gynecology, and orthopedics. In China, 3D imaging is becoming increasingly essential, with a developing market for 3D imaging equipment, software, and services.

china 3D imaging market analysis

Market Dynamics

Market Growth Drivers

Several reasons are driving the 3D imaging market in China, including the expanding healthcare industry, rising healthcare spending, and technological advancements. China's rapidly aging population and rising chronic illness rates are driving up demand for better medical imaging technologies. As the Chinese economy expands, the government is increasing its investments in healthcare, including the development and application of 3D imaging technologies. China is also a technological and innovation frontrunner, with numerous local firms producing cutting-edge 3D imaging technologies. These elements are combined to drive the growth of China's 3D imaging industry.

Market Restraints

Recurrent COVID-19 breakouts, the likelihood of further mobility restrictions, and precautionary conduct to halt the virus's transmission caused economic activity to be disrupted for a longer period of time than predicted this may affect the market in the form of regulatory hurdles, high costs, and a shortage of trained healthcare professionals. 3D imaging technology regulation in China is complicated, and certain modern 3D imaging methods may face regulatory restrictions or require extra certifications and permissions. Furthermore, 3D imaging solutions may be costly, and not all patients may be able to afford these operations.

Competitive Landscape

Key Players

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Philips Healthcare
  • Mindray Medical International Limited (CHN)
  • Beijing Surewell Medical Equipment Co., Ltd (CHN)
  • Shenzhen Unicomp Technology Co., Ltd. (CHN)
  • Fussen Technology Co Ltd (CHN)
  • SHANGHAI JPS DENTAL CO., LTD (CHN)

Notable Deals

  1. January 2023, Canon Medical Systems Corporation announced a Partnership with ScImage, Inc., as it plans to expand in image exchange solutions and the cardiac market
  2. In November 2022, GE HealthCare announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives

Healthcare Policies and Regulatory Landscape

The Chinese government and multiple regulatory authorities, especially the National Medical Products Administration (NMPA) and the China Food and Drug Administration (CFDA), determine the legislation and guidelines for 3D imaging in China. These organizations are in charge of overseeing the design, manufacture, and usage of 3D imaging equipment, including 3D imaging systems. All medical products, including 3D imaging systems, must be authorized by the NMPA or the CFDA before they may be marketed and sold in China. This procedure entails a thorough examination of the device's safety and efficacy, as well as an examination of its production and quality control systems.

Reimbursement Scenario

In China, there are 2 types of public health insurance schemes:

  1. The Urban Employees Basic Medical Insurance (UEBMI) for employees
  2. The New Rural Cooperative Medical Scheme (NCMS), URBMI, and URRBMI are for other citizens and/or employees who do not qualify for the UEBMI

The coverage of 3D imaging solutions varies based on the type of scan and the insurance program. Usually, the reimbursement only covers a percentage of the overall cost of the examination, with patients paying for the remainder out of pocket. To make 3D imaging services more accessible to patients, the government is working to improve reimbursement processes and increase the amount covered by the NHSA.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

  • X-ray Imaging Systems
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

  • Cardiology
  • Neurology
  • Orthopedics
  • Gynecology
  • Oncology
  • Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

  • Stationary
  • Mobile

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 October 2023
Updated by: Vidhi Upadhyay

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up